These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10562812)
1. Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma. Hirvikoski P; Kellokoski JK; Kumpulainen EJ; Virtaniemi JA; Johansson RT; Kosma VM J Clin Pathol; 1999 Jun; 52(6):440-4. PubMed ID: 10562812 [TBL] [Abstract][Full Text] [Related]
2. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer. Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716 [TBL] [Abstract][Full Text] [Related]
3. Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Hirvikoski P; Kumpulainen E; Virtaniemi J; Pirinen R; Salmi L; Halonen P; Johansson R; Kosma VM Eur J Cancer; 1999 Feb; 35(2):231-7. PubMed ID: 10448265 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Xie X; Clausen OP; Boysen M Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):897-902. PubMed ID: 12162767 [TBL] [Abstract][Full Text] [Related]
5. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Jeannon JP; Soames J; Lunec J; Awwad S; Ashton V; Wilson JA Clin Otolaryngol Allied Sci; 2000 Feb; 25(1):23-7. PubMed ID: 10764233 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053 [TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Lam KY; Law S; Tin L; Tung PH; Wong J Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612 [TBL] [Abstract][Full Text] [Related]
12. Expression of the the cyclin-kinase inhibitors p21(WAF1) and p27(Kip1) and the p53 tumor suppressor genes in adult-onset laryngeal papillomas. Erdamar B; Keles N; Kaur A; Suoglu Y; Kiyak E Eur Arch Otorhinolaryngol; 2002 Nov; 259(10):516-20. PubMed ID: 12434183 [TBL] [Abstract][Full Text] [Related]
13. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102 [TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
15. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Pulkkinen JO; Klemi P; Martikainen P; Grénman R Anticancer Res; 1999; 19(1B):703-7. PubMed ID: 10216480 [TBL] [Abstract][Full Text] [Related]
17. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas. Ohashi K; Nemoto T; Eishi Y; Matsuno A; Nakamura K; Hirokawa K Virchows Arch; 1997 May; 430(5):389-95. PubMed ID: 9174629 [TBL] [Abstract][Full Text] [Related]
18. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092 [TBL] [Abstract][Full Text] [Related]
20. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Izawa H; Yonemitsu N; Shin T; Sugihara H Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]